Pinhas (Peter) Dartal 01 June 2010 0544871990 QA role in development of Percutaneous Aortic Valve prosthesis.

Slides:



Advertisements
Similar presentations
Challenges in Using a Formal Decision Analysis Approach to Medical Device Approval Larry Kessler, Sc.D. Director, Office of Science and Engineering Laboratories.
Advertisements

Medical Device Software Development
Regulatory Pathway for Platform Technologies
Regulation of Medical Devices Celia M. Witten, Ph.D., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation.
Overview of Device Regulations David Arvelo Small Business Representative.
"Determining the Regulatory Pathway to Market" Classification Heather S. Rosecrans Director, 510(k) Staff Office of Device Evaluation Center for Devices.
Strengthening the Medical Device Clinical Trial Enterprise
510k Submission Overview Myraqa, Inc. August 22, 2012.
Rheumatic Heart Diseases Ahmad Osailan. Fast review of the heart.
ATS 3f® Aortic Bioprosthesis
THE USE OF A TRANSCATHETER AORTIC VALVE TO REPLACE A DEFECTIVE AORTIC VALVE WITHOUT OPEN-HEART SURGERY Natalie Garda and Adam Cotter Heart disease is the.
IRB PRESENTATION REGULATORY PATHWAYS HDE – PMA William Hellenbrand MD Director – Pediatric Cardiology Columbia University College of Physicians & Surgeons.
University of Medicine and Dentistry of New Jersey John L. Ricci, Ph.D., Department of Orthopaedics History and Scope of Biomaterials J. L. Ricci, Ph.D.
Medical Devices Approval Process
External Defibrillators: Recalls, Inspections, and the Quality System Regulation Melissa Torres Office of Compliance December 15, 2010.
CE Marking for Medical Devices “Basic Steps to Compliance” Ján Petrík, PhD. EVPÚ, a.s. Nová Dubnica Medical Devices Branch Office Bratislava 4/27/06 EVPÚ,
+ Medical Devices Approval Process. + Objectives Define a medical device Be familiar with the classification system for medical devices Understand the.
INTERNATIONAL. CAUTION: For distribution only in markets where CoreValve® is approved. Not for distribution in U.S., Canada or Japan. Medtronic, Inc
Biomedical Engineering Design and the Promotion of High Value Relationships with Clinical Medicine Robert Hitchcock.
Classification of HLA Devices FDA Introduction & Background Sheryl A. Kochman CBER/OBRR/DBA.
1 THE UNIQUE ROLES OF IRB IN MEDICAL DEVICE CLINICALL TRIAL Chiu Lin, Ph.D. CITI, May, 2009 CITI, May, 2009.
Prof. Moustafa M. Mohamed Vice dean Faculty of Allied Medical Science Pharos University in Alexandria Development and Regulation of Medical Products (MEDR-101)
Regulatory Problems Moderators: Eugene Chen and Michael Kochman, MD.
The Medical Device Pathway as a Legal Onramp for Futuristic Persons THE FUTURE T HE M EDICAL D EVICE P ATHWAY AS A L EGAL.
Trans-catheter Aortic Valve Replacement: a UK update. Dr Martyn Thomas Guys and St Thomas’ Hospital.
INTRODUCTION TO RA.
Utilizing Science & Technology and Innovation for Development Transcatheter Therapies For Congenital & Structural Heart Disease Marriott Hotel- Amman,
Development and Regulation of Medical Products (MEDR-101)
A shifting paradigm of care: Advances in transcatheter heart valve procedures Sandra Lauck MSN, RN, CCN(C) Clinical Nurse Specialist, Arrhythmia Management.
The Impact of Regulations on Medical Device Design Richard C. Fries, PE, CRE Manager, Reliability Engineering Datex-Ohmeda Madison, Wisconsin.
Utah Life Science Summit Nov Phil Triolo, PhD RAC President, Phil Triolo and Associates LC.
Joel Gerber Zachary Reaver Kurt Schilling.  Provides physical proof of development  Maintains product design knowledge base  Meets government and corporate.
UPCOMING CHANGES TO IN-VITRO DIAGNOSTICS (IVDs) AND LABORATORY DEVELOPED TESTS (LDTs) REGULATIONS Moj Eram, PhD November 5, 2015.
VIRTUAL SIMULATION OF TRANSCATHETER AORTIC VALVE IMPLANTATION Jenna Smetana and Jessica Sider, Swanson School of Engineering THE TAVI PROCEDURE IS FEASIBLE.
AMERICAS | ASIA PACIFIC | EMEA Medical Devices: Concept to Commercialization How to avoid delays in getting your product cleared/approved by FDA Robert.
WORKSHOP ON ACCREDITATION OF BODIES CERTIFYING MEDICAL DEVICES INT MARKET TOPIC 9 CH 8 ISO MEASUREMENT, ANALYSIS AND IMPROVEMENT INTERNAL AUDITS.
Device regulations USA Dr Phil Warner. USA Regulations MEDICAL DEVICES Food, Drug & Cosmetics Act Medical Device Amendments of 1976 (and other things)
EXPANDING INDICATIONS OF TRANSCATHETER HEART VALVE INTERVENTIONS. JACC CARDIOVASCULAR INTERVENTION. DR.RAJAT GANDHI.
November 9, 2015 February 20, 2017 Using real world evidence – industry perspective Pma indication expansion Melissa hasenbank, phd Sr. Clinical Research.
Medical Device Software Development
PERCUTANEOUS PULMONARY VALVE REPLACEMENT:
A: The Edward SAPIEN balloon expandable valve (Edwards Lifesciences, Irvine, CA) incorporates a stainless steel frame, bovine pericardial leaflets, and.
Dental Standards & Testing Methods
Use of Postmarket Data to Support Premarket Approvals
Percutaneous valve devices
Division of Cardiovascular Devices
Design & Product Development Larry L Wood
Direct Flow Medical Experience with a Conformable, Repositionable, Retrievable, Percutaneous Aortic Valve Reginald Low MD University of California,Davis.
JP Academia HISASHI SUGIYAMA
Carolyn D. Vaughan FDA Lead Reviewer / Mechanical Engineer
Valve Durability Considerations: Fluid Dynamic Principles, Assessment Techniques, Predictors, and Minimum Standards Jorge H. Jimenez, Ph.D. Georgia Institute.
EVOLUT R, Next Generation, and Future
TAVR-Endocarditis Tarek Chami, MD
Adherence to the Labeling
Review of the Latest OUS Data from the Self-Expanding Valve Studies
Premarket Notification 510(k) process
Direct Flow Medical Experience with a Conformable, Repositionable Retrievable Percutaneous Aortic Valve Reginald Low MD University of California, Davis.
The Current PMA Requirements
Opportunities to Study Valve Iterations and Modifications in the US
Improved Technology: Evaluating Device Modifications
Structural Heart Disease and Devices in Japan and USA
TAVR: Similarities and Differences in the US and Japan
Nat. Rev. Cardiol. doi: /nrcardio
Implantable Medical Devices: Accelerating Standards Development to Streamline Regulation Joshua Price | August 2,
Linda M. Chatwin, Esq. RAC Business Manager, UL LLC
Figure 1 Types of surgical and transcatheter aortic valves
Transapical transcatheter aortic valve-in-valve implantation: Clinical and hemodynamic outcomes beyond 2 years  Jian Ye, MD, FRCSC, John G. Webb, MD,
Medical Device Design and Development
The Process of TAVR Development
The transapical approach for aortic valve implantation
Presentation transcript:

Pinhas (Peter) Dartal 01 June QA role in development of Percutaneous Aortic Valve prosthesis

Transcatheter Heart Valve Prosthesis Tested to ISO5840 and FDA surgical Heart Valve Guidance In-vitro durability simulating 5 years (200 million cycles) Frame fatigue testing simulating 15 years (600 million cycles)

Regulatory requirements Medical device field is highly regulated so even the most brilliant new medical devices are of no value, if needed approvals from relevant authorities are not secured. Quality assurance and regulatory affairs departments play a major role in getting the required approvals.

Regulatory requirements In the United States all devices in commercial distribution are classified in class I, II, or III, depending on the degree or regulation necessary for the reasonable assurance of safety and effectiveness of the device.

Regulatory requirements Premarket notification- 510(K) is required by FDA in order to establish substantial equivalence in safety and effectiveness to a medical device already marketed in the United States.

Regulatory requirements Premarket Approval Application (PMA) is required by FDA for class III devices and is, in effect a private license granted for marketing a particular medical device.

Regulatory requirements An Investigational Device Exemption (IDE) is permission from clinical authorities to conduct clinical studies on human subjects about a new device, or a new intended use or modification for an existing device.

Regulatory requirements In Europe all devices in commercial distribution are classified in class I, IIa, IIb, or III, and require Conformité Européenne, "European conformity" (CE) marking for commercial distribution, to be issued by a Notified Body.

Aortic stenosis Aortic stenosis may begin as a result of infection, rheumatic fever or a congenital abnormality. Typically, the valve tissue becomes scarred, inflamed or thickened. Calcium may collect on the valve, reducing the flexibility of the valve leaflets As the valve leaflets lose their flexibility, the area through which blood flows is reduced. As it becomes harder to push blood through the valve, the muscles of the heart chamber wall stretch and thicken, leading to an increased likelihood of heart failure.

Medical device companies Majority of employees are engineers Number of M.D’s is very small (if at all)

QA role in development Design Controls – framework that must be used for devices development and for understanding the intent of regulation Design and Development Planning Design Input Design Output Design Review

QA role in development Design Verification Design Validation Design Transfer Design Changes Design History File QA is involved in all projects

THV The Transcatheter Heart Valve (THV), is a prosthetic device intended for use for patients who suffer from Severe Aortic Valve Stenosis. It is an artificial heart valve designed for a less invasive implantation by transluminal catheter technique without thoracotomy and open-heart surgery.

Balloon expandable Stainless Steel or Cobalt Chromium frame:  Consistency & durability with non-conformable, Radial strength for concentric shape that creates uniform stress on leaflets and limits contact with frame  symmetrical, discreet frame –Radial strength for concentric shape that creates uniform stress on leaflets and limits contact with frame  Consistency & durability with non-conformable, symmetrical, discreet frame –Radial strength for concentric shape that creates uniform stress on leaflets and limits contact with frame

Bovine pericardial leaflets: Matched for deflection and thickness for optimal coaptation and durable hemodynamic performances

Crimper

Delivery system

One Valve with Two Complementary Approaches One Valve with Two Complementary Approaches Transapical Delivery System Transfemoral Delivery System

Edwards SAPIEN™ THV using the RetroFlex 3™ Transfemoral Delivery System

Edwards SAPIEN™ THV using the Ascendra™ Transapical Delivery System